Frequently Asked Questions


When a breast prosthesis is going to be placed, a pocket is designed where it will be placed.

Normally, the organism, in the presence of a foreign body, creates a connective tissue that surrounds and isolates it completely. This tissue will form a coating around the prosthesis of soft consistency, in the form of a thin film, which will not change the shape or position of the prosthesis.

We call this peri-prosthetic capsule tissue, and it exists in all patients undergoing breast prostheses.

Capsular contracture occurs when this tissue is too thick, too fibrous, much harder than usual, and conditions the initial cavity to change, sometimes from position, causing the implant to move, usually towards above, and sometimes in size, contracting itself and causing the prosthesis to not fit in its cavity, then folds can form and acquire the form of “ball” or “ball” characteristic.

If the encapsulation occurs in a single breast, an asymmetry can be observed, and if it is on both sides, the breasts will feel harder than normal, but symmetry can be maintained.

The causes of encapsulation are multiple and sometimes unknown. Among the known are bruises, infections or contaminations of the implant, lack of mobility in the post-operative, individual hyper reactivity of the patient, contusions, gel exudation of the implant and rupture.

To prevent the occurrence of encapsulation, the most important are the preventive measures, which must be rigorously applied and the careful monitoring of the evolution of periprosthetic tissue formation, in order to detect the appearance of capsular contracture in its initial phases and initiate a treatment.


Most implants have a manufacturer’s warranty of 10 years, which does not mean that this is the actual duration.

The current implants of highly cohesive gel, with 5 layers of coating, offer us greater security in terms of the implant’s duration time once introduced into the body.

The real durability time will be known as the years go by and we observe the evolution of the patients who underwent surgery.

Our opinion is that if it is observed that the breasts are healthy, that is to say, if there is no problem, it is not necessary to replace the prosthesis.

In case of discomfort or suspected rupture of the implant, diagnostic tests should be performed to rule out or confirm the rupture.

In any case, the intervention for the replacement of the prosthesis is much simpler than that of the initial placement of the implant, except in the case that it has taken a long time to take out the implant and the organism has formed a defensive capsule around it.


The fact of carrying a breast implant does not contraindicate breastfeeding; The possibility of breastfeeding depends on the preservation of the integrity of the mammary gland, that is, not having injured the ducts through which the milk must circulate.

This is always achieved by the axillary route, the submammary groove pathway and, in some cases, the areolar pathway.

The possibility of breastfeeding is not recommended in most cases of areolar route, when it is associated with mastopexy and in most cases of tubular breasts.


I think this section is very important, and patients are very concerned.

Breast tumors, whether benign or malignant, are very frequent, affecting up to one in 10 women throughout their lives.

In multiple studies performed with patients who have breast implants, it has NOT been observed that there is a greater frequency of appearance of mammary tumors.

What was observed, and this is beneficial for the patients, is that these lesions were diagnosed in more initial stages, due to the better palpation and the post-operative controls that are practiced.

The problem appears regarding the early radiological diagnosis of breast lesions.

Obviously, the surgery that affects the breast leaves some traces in it, and at first can confuse the differential diagnosis on the images that are being studied.

Our advice, in this case is the following:

  • In case of having family with breast cancer history, in patients with fibrocystic mastopathy, or breasts difficult to evaluate by the gynecologist or the radiologist, the axillary route and the retropectoral situation would be indicated as the first option.
  • The radiologist should be informed of the intervention performed, which will decide the test and the most appropriate projection for each case.

Before the intervention, the surgeon must provide all the documentation regarding the benefits and possible complications that may appear.

This documentation is specific to each surgical intervention, and must be read and understood before being signed by the patient.

This document is called informed consent, since it authorizes the surgeon to practice the intervention, and it is essential to deliver it before surgery.

We use the informed consents written and distributed to its members by the SECPRE (Sociedad Española Cirugía Plástica Reparadora Estética).


The size, shape and type of the implant placed must be decided between the patient and the surgeon.

Through the images of other patients who have undergone surgery, we can have an approximate idea of ​​the desired volume, but in any case, we must carry out some personal measurement tests.

The photographs do not take into account the patient’s height, span and chest measurements, as well as the projection of the ribs and muscle development; all this very important when deciding the type and size of the implant.

In the visit with the surgeon we practice measurements and tests that will help us decide the most adequate volume for each patient, taking into account their personal tastes.

If you have any questions or want to contact us, you can contact us in the section “contact”.

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.

Aviso de cookies